Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzagolix (OBE2109) for Heavy Menstrual Bleeding in Uterine Fibroids
NCT03070951Phase 3Completed
- Sponsor
- ObsEva SA
- Start
- May 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of linzagolix in Uterine Fibroids (UF), sponsored by ObsEva SA. Started May 2017; status: completed.
02
Drugs
linzagolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03070951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070951.